Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

LillyDirect Foundayo vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
LillyDirect Foundayo logo

LillyDirect Foundayo

8.1
★★★★4.1/5

Best for: the cheapest legal brand-name GLP-1

Visit LillyDirect Foundayo
VS
Vytora Health logo

Vytora Health

8.4
★★★★4.2/5

Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 states

Visit Vytora Health

LillyDirect Foundayo and Vytora Health are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, LillyDirect Foundayo starts lower at $149/mo versus $150/mo, and Vytora Health edges ahead overall (8.4 vs 8.1 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

LillyDirect Foundayo

Foundayo (with commercial insurance + savings card)Brand-name
$25/mo
orforglipron

Requires commercial insurance; Medicare/Medicaid not eligible. 'Starting at $25 per month'.

Foundayo 0.8 mg (self-pay)Brand-name
$149/mo
orforglipron

Regular self-pay price, 1-month (30-day) supply.

Foundayo 2.5 mg (self-pay)Brand-name
$199/mo
orforglipron

Regular self-pay price, 1-month supply.

Foundayo 5.5 mg & 9 mg (self-pay)Brand-name
$299/mo
orforglipron

Regular self-pay price, 1-month supply.

Foundayo 14.5 mg & 17.2 mg (self-pay)Brand-name
$349/mo
orforglipron

Regular self-pay price $349; available for $299 via an automatic purchase offer ONLY if you complete your refill within 45 days of the delivery/receipt date of your previous Foundayo fill (14.5/17.2 mg only).

Medicare Part D Bridge Program (insurance-gated)Brand-name
$50/mo
orforglipron

For eligible Medicare Part D patients. A bridge program, not a standing retail price.

Vytora Health

All dosesCompounded
$180/mo
semaglutide
3-mo bundle ($450 billed)Compounded
$150/mo
semaglutide
All dosesCompounded
$249/mo
tirzepatide
3-mo bundle ($599 billed)Compounded
$200/mo
tirzepatide
Brand 5/7.5/10/12.5/15 mgBrand-name
$1399/mo
mounjaro
Brand 2.5/5/7.5/10/12.5/15 mgBrand-name
$1399/mo
zepbound

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 500+ providers' prices on their own sites and email you when tracked prices move.

What’s included

LillyDirect Foundayo

Inclusions not disclosed.

Vytora Health

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

LillyDirect Foundayo

8.1/10

Overall

Vytora Health

8.4/10

Value25%

9.0A
vs
B
8.0

Effectiveness25%

7.0A
vs
B
8.5

User Experience15%

7.5A
vs
B
8.0

Trust & Safety15%

9.3A
vs
B
9.3

Accessibility10%

9.0A
vs
B
8.5

Support10%

6.5A
vs
B
8.4

Features & Coverage

FeatureLillyDirect FoundayoVytora Health
Starting Price$149/mo$150/mo
Features5 features8 features
States Available5151
Compounded✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About LillyDirect Foundayo

Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. With the Lilly Savings Card, commercially insured patients pay $25/month; cash-pay patients pay $149-$299/month depending on labeled dose. Requires a valid US prescription from any licensed prescriber.

Read our full LillyDirect Foundayo review →

About Vytora Health

Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides. It names its pharmacy partners publicly — Vials Pharmacy and Greenwich Biosciences — and discloses its operating physician group, uncommon transparency for the category. Compounded semaglutide runs $180/mo ($150 on a 3-month bundle) and tirzepatide $249/mo ($200 bundled).

Read our full Vytora Health review →

Pros & Cons

LillyDirect Foundayo

What we like

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Watch-outs

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Vytora Health

What we like

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
  • Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options

Watch-outs

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Our Verdict

Winner: Vytora Health

Vytora Health edges out LillyDirect Foundayo with a higher overall score of 8.4/10 and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. LillyDirect Foundayo remains a solid alternative, especially if you're looking for the cheapest legal brand-name GLP-1.

Choose LillyDirect Foundayo if…

You want the cheapest legal brand-name GLP-1 and a starting price around $149/mo.

Choose Vytora Health if…

You want compounded or brand-name GLP-1 with named pharmacy partners, 50 states and a starting price around $150/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.2

Gala

Compounded GLP-1/GIP combo on a yearly plan with free shipping

6.9

TMates

Nationwide compounded GLP-1 availability including Puerto Rico

7.9

Trimi Health

Budget-conscious shoppers

LillyDirect Foundayo vs Vytora Health: FAQ

LillyDirect Foundayo is cheaper. Its lowest ongoing monthly cash price is $149/mo, compared with $150/mo for Vytora Health. We compare standing (not first-month promo) prices so the figures reflect what you'd actually pay month to month.
Vytora Health scores higher overall at 8.4/10 versus 8.1/10, and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. That said, LillyDirect Foundayo is a better fit if you want the cheapest legal brand-name GLP-1.
LillyDirect Foundayo and Vytora Health both list availability in 51 states.
Neither LillyDirect Foundayo nor Vytora Health is currently an affiliate partner, so we earn no commission from either. We rank all providers editorially using the same six-dimension framework and disclose any commercial relationships.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring LillyDirect Foundayo and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.